Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TORONTO, June 30, 2020 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today that it has completed the previously-announced buyout...
-
New York, June 30, 2020 (GLOBE NEWSWIRE) -- The Global Cadmium Pigments Market is forecast to reach USD 361.8 million by 2027. The growing prevalence of plastic applications that require cadmium...
-
BOISE, ID, June 30, 2020 (GLOBE NEWSWIRE) -- Albertsons Companies (NYSE: ACI) announced today that 100 percent of the seafood in its celebrated waterfront BISTRO® and Open Nature® lines of Own...
-
ANDOVER, Mass., June 30, 2020 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a leader in trusted, secure mission-critical technologies for aerospace and defense, announced...
-
- Topline data from ENHANCE-IT study of MAT9001 vs. Vascepa® expected in Q1 2021 - - EnACT remains on track for cohort progression in Q4 2020 - BEDMINSTER, N.J., June 30, 2020 (GLOBE...
-
Fort Myers, Fla., June 30, 2020 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) recently celebrated the start of construction of its new Trinity Cancer Center. When...
-
REDWOOD CITY, Calif. and BOSTON, June 30, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit...
-
CARLSBAD, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
-
MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
-
HOUSTON, June 30, 2020 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening...